Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

$5.09

+$0.05 (+0.99%)

Nov 2, 2026, 1:39 PM ET · Market open

Fiscal Year Period Ending	FY 2024 Jun 30, 2025	FY 2023 Jun 30, 2024	FY 2022 Jun 30, 2023	FY 2021 Jun 30, 2022
Revenue	11.32M	10.05M	9.7M	10.66M
Cost of Revenue	2.53M	2.25M	2.34M	2.18M
Gross Profit	8.79M	7.8M	7.36M	8.48M
Operating Income	-2.18M	2.2M	2M	2.47M
Interest Income	83.27K	n/a	295.59K	246.71K
Pretax Income	-12.51M	2.4M	2.13M	2.39M
Net Income	-12.09M	2.07M	1.78M	1.98M
Selling & General & Admin	6.54M	3.64M	3.27M	4.04M
Research & Development	n/a	n/a	n/a	n/a
Other Expenses	4.44M	1.97M	2.1M	1.96M
Operating Expenses	10.98M	5.61M	5.36M	6.01M
Interest Expense	203.95K	176.24K	238.6K	320.87K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	13.5M	7.86M	7.7M	8.18M
Income Tax Expense	-417.39K	331.76K	348.28K	408.48K
Shares Outstanding (Basic)	1.57M	1.35M	1.35M	1.35M
Shares Outstanding (Diluted)	1.57M	1.35M	1.35M	1.35M
EPS (Basic)	-5.16	1.14	0.96	1.07
EPS (Diluted)	-5.16	1.14	0.96	1.07
EBITDA	-11.12M	3.11M	2.93M	3.28M
EBIT	-12.3M	2.58M	2.37M	2.71M
Depreciation & Amortization	1.18M	528.73K	557.13K	575.92K